- Molecular self-assembly of macroporous parallelogrammatic pipes
-
The pipes, the pipes are calling: Organic parallelogram-shaped pipes of micrometer dimensions have been obtained by simply allowing drops of a solution of low-molecular-weight compounds to evaporate. This unique structure is formed by self-templated crystal growth during the evaporation. The mechanism of formation involves two polymorphic crystal forms in dynamic nonequilibrium conditions. (Figure Presented).
- Seo, Myungeun,Seo, Gon,Sang, Youl Kim
-
-
Read Online
- DIAMINE COMPOUND AND METHOD FOR PRODUCING SAME
-
The present invention provides a novel diamine compound capable of producing a polymer which exhibits greatly enhanced mechanical properties and heat resistance while maintaining transparency. A film including a polymer produced using the diamine compound has excellent transparency, heat resistance, mechanical strength and flexibility, and thus can be used in various fields, such as in a device substrate, a display cover substrate, an optical film, an Integrated circuit (IC) package, an adhesive film, a multi-layer flexible printed circuit (FPC), a tape, a touch panel and an optical disc protection film, and the like.
- -
-
Paragraph 0160-0162; 0166
(2019/10/12)
-
- NOVEL CARBOXAMIDES, PRODUCTION AND USE THEREOF AS MEDICAMENTS
-
The invention relates to novel carboxamides of general formula (I), in which R1 to R5 are as defined in claim 1, the tautomers, enantiomers, diastereomers, mixtures and salts thereof, and the production and use thereof as medicaments. The compounds of the above general formula (I) have useful pharmacological effects, in particular an anti-thrombotic effect and a factor Xa inhibiting effect.
- -
-
Page/Page column 22
(2010/02/06)
-
- 2,3-quinoxalinediones for use as neuroleptics
-
Heterocyclic dihydroxyquinoxaline compounds having the formula STR1 wherein R 1 is hydroxy, alkoxy, aryloxy, aralkyloxy, cycloalkylalkoxy, cycloalkoxy, or acyloxy; andR 5, R 6, R 7 and R 8 independently are hydrogen, NO 2, halogen CN, SO 2 NR''R'', SO 2 R'', CF 3, or OR'', wherein R'' is hydrogen or C 1-4 -alkyl;The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use.The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters, particularly the quisqualate receptors, and especially as neuroleptics.
- -
-
-
